Escalon Medical Corp. income statement ESMC

Annual Quarterly

In Q4 of fiscal 2026, the quarter ended Jun 30, 2026, Escalon Medical Corp. reported revenue of $3.9 million. Net income was $1.8 million, a profit margin of 46.1%. Operating income came to $568,511, an operating margin of 14.7%. Diluted earnings per share were $0.06.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line	Q4 FY2026 Jun 30, 2026	Q3 FY2026 Mar 31, 2026	Q2 FY2026 Dec 31, 2025	Q1 FY2026 Sep 30, 2025	Q4 FY2025 Jun 30, 2025	Q3 FY2025 Mar 31, 2025	Q2 FY2025 Dec 31, 2024	Q1 FY2025 Sep 30, 2024
Revenue	4	3 -24.9%	4 +11.5%	3 -3.8%	—	3 +28.9%	3 +12.2%	3
Cost of revenue	2 +32.4%	2 -11.3%	2 +23.6%	2 -0.9%	1 -27.7%	2 +18.7%	2 +2.4%	2 -4.9%
Gross profit	2	1 -40.8%	2 -1.1%	1 -7.6%	—	2 +43.3%	2 +24.8%	1
Research and development	0 -57.4%	0 -81.8%	0 -15.9%	0 +53.4%	0 +68.6%	0 +5.7%	0 +5.6%	0 -33.4%
Selling, general and administrative	1 +4.1%	1 +15.3%	1 +14.1%	1 +0.7%	1 +3.8%	1 +3.7%	1 -1.9%	1 -0.1%
Operating expenses	1	1 +3.2%	1 +10.6%	1 +6.7%	—	1 +4.0%	1 -1.0%	1
Operating income	1 +252.9%	-0 -251.9%	0 -61.4%	-0 -652.2%	-0 -368.8%	0 +276.3%	0 +462.9%	-0 -72.3%
Income tax	-1	0	0	0	0	0	0	0
Net income	2 +569.1%	2 +774.3%	0 -60.3%	-0 -644.5%	-0 -382.5%	0 +267.4%	0 +422.4%	-0 -52.0%
Net income to common	1 +533.6%	1 +790.6%	0 -64.3%	-0 -459.6%	-0 -269.2%	0 +177.4%	0 +237.4%	-0 -32.1%
Basic EPS	0.12 +533.6%	0.16 +700.0%	0.01 -50.0%	-0.03 -200.0%	-0.03 -269.2%	0.02 +200.0%	0.02 +300.0%	-0.01
Diluted EPS	0.06 +523.5%	0.16 +700.0%	0.01 -50.0%	-0.03 -200.0%	-0.01 -186.5%	0.02 +200.0%	0.02 +300.0%	-0.01
Weighted average shares, basic	7 +0.0%	7 +0.0%	7 +0.0%	7 +0.0%	7 +0.0%	7 +0.0%	7 +0.0%	7 +0.0%
Weighted average shares, diluted	15 +2.4%	15 +2.4%	14 +2.4%	7 +0.0%	15 +95.7%	14 +91.0%	14 +89.9%	7 +0.0%
Other measures
Depreciation and amortization	0 -64.9%	0 -65.9%	0 -14.6%	0 -23.1%	0 -55.6%	0 +145.3%	0 -18.9%	0 -3.6%
EBITDA	1 +257.3%	-0 -246.1%	0 -59.7%	-0 -1091.7%	-0 -330.5%	0 +286.1%	0 +555.3%	-0 -253.6%
Interest coverage	—	-130.86x	127.24x	-47.11x	—	—	—	—
Margins
Gross margin	50.41%	36.29%	43.33%	41.89%	—	46.05%	48.87%	43.62%
Operating margin	14.73%	-16.07%	2.75%	-7.58%	—	7.95%	7.95%	-0.97%
Profit margin	46.14%	90.99%	2.72%	-8.97%	—	7.81%	7.64%	-1.16%
EBITDA margin	14.80%	-15.96%	2.98%	-7.27%	—	8.20%	8.25%	-0.59%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as: ESMC (OTC)
Fiscal year ends: June 30
Incorporated in: PA
Headquarters: Wayne, PA
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 862668

Other Electromedical & Electrotherapeutic Apparatus companies

All 31 Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.